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Objective: The primary aim of this study was to assess if self-reported measures of walking limitation correlate better with
a community-based assessment of maximum walking distance (MWD) than they do with laboratory-based tests in
patients with intermittent claudication. A secondary aim was to examine the effect of prior objective testing on these
correlations.
Methods: Thirty-one patients completed three self-report tools (self-reported MWD; Walking Impairment Questionnaire
[WIQ]; Estimation of Ambulatory Capacity by History-Questionnaire [EACH-Q]) immediately before and approxi-
mately 1 week after a series of objective tests (incremental treadmill walking test, 6-minute walk test, 1-hour global
positioning system [GPS] recording of a community walk). We analyzed the feasibility of the self-report tools in terms of
number of errors and their correlation (r) with objective measures.
Results: The correlations of self-report tests to GPS-MWD (range, .579-.808) were consistently higher than with the
treadmill test (range, .310-.584) and 6-minutewalk test (range, .414-.613). TheWIQhad the highest proportion of errors,
both at ﬁrst and second completion (58% and 42%, respectively), compared with self-reported MWD (23% and 13%,
respectively) and the EACH-Q (6.5% and 13%, respectively). Correlations were improved with the second set of self-report
tests (range, .310-.595 to .414-.808).
Conclusions: The fact that all self-report tools correlated better with a community-based measure of MWD using GPS
than with laboratory results conﬁrms that they measure what they aim to: community-based MWD. In addition,
prescription of a community walk might help patients to better estimate their walking limitation. (J Vasc Surg
2013;57:1227-34.)Lower extremity peripheral artery disease (PAD) is
widely prevalent among the elderly population.1 A common
symptom in PAD is intermittent claudication, which is pain
in the lower limb during walking caused by an insufﬁcient
blood ﬂow increase to cover metabolic demand. Intermit-
tent claudication can cause a marked reduction in walking
capacity. The “maximum walking distance” (MWD),
deﬁned as the distance at which pain forces the patient to
stop walking, is important for assessing the magnitude of
walking impairment and the impact of therapy. Walking
limitation can be measured “objectively” or estimated
“subjectively.”
For years, treadmill testing has been used as a gold
standard in the assessment of MWD in claudicants2
because a low correlation has often been found between
treadmill MWD and self-report measures of walking limita-
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a speciﬁc threshold, was used both sides of the Atlantic and
formed part of the guidelines of the TransAtlantic Inter-
Society Consensus (TASC) for the diagnosis and treatment
of intermittent claudication.6 Treadmill protocols are either
incremental,7 constant load,3,4 or a combination of both.8
The variety of protocols, and the fact that treadmill testing
is expensive, time consuming, and often not accessible, rai-
ses the question of whether treadmill testing is practical in
the clinical setting and can really be considered a gold
standard. It is of interest to note that currently, on the
TASC internet homepage (http://www.tasc-2-pad.org/),
“reduced treadmill performance” has an equal decision value
as a “history of signiﬁcant exercise limitation” or a “reduced
function by questionnaire.” This position appears pragmatic
and consistent with the idea that treadmill testing is difﬁcult
to implement.9 Presently, in most clinical routines, the pres-
ence and importance of self-reported disability is considered
one of the major and easily attained factors guiding clinical
decision.
How conﬁdent can we be that these self-reports
are valid? We hypothesized that the largely published
low correlation of self-reports to laboratory-measured
MWD might just be that self-reported measures reﬂect
real-life MWD instead of performance on an artiﬁcially
created walking test. We recently reported that global
positioning system (GPS) data loggers could be used to
provide information on unsupervised community-based
outdoor walking, assumed to better reﬂect real life.10-121227
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ures and community-based outdoor walking has never
been reported. It is also unknown if the quality of self-
reported estimates can be improved, for example, by
making patients ﬁrst undertake a series of walking tests.
The primary aim of this study was to assess the
construct validity of three different self-report tools by
assessing their relationship with three different objective
tests in a group of patients with intermittent claudication
(ie, is each self-report tool measuring what it claims to be
measuring?). Secondary aims were to assess the difﬁculty
of completing different self-report tools (ie, does the instru-
ment face practical or technical issues resulting in missing
values?) and measure the learning effect of self-reports (ie,
is the number of errors reduced at the second completion
compared with the ﬁrst? Is the correlation with objective
tests improved for the second set of self-reports?).
It was expected that a learning effect would occur from
both repeating self-reports and completing objective tests
between two sets of self-reports. However, to the best of
our knowledge, the proof and magnitude of the improve-
ment resulting from questionnaire resubmission, if any,
has never been reported in the literature. Our primary
hypothesis was that self-report scores would show a better
correlation with a community-based outdoor measure of
MWD than with laboratory-based measures. A secondary
hypothesis was that prior completion of objective walking
tests would improve the validity of self-report tools.
METHODS
Study design and population
With local Research Ethics Committee approval, 37
patients with intermittent claudication attributable to PAD
were recruited from the Shefﬁeld Vascular Institute at the
Northern General Hospital, Shefﬁeld, United Kingdom.
The diagnosis of PAD was based on an ankle-brachial
index <.90 at rest on one or both legs and/or a prior imag-
ing investigation showing stenoses or occlusions of the aorta
and/or lower-limb arteries. Exclusion criteria included (1)
absence of PAD, (2) asymptomatic PAD, (3) rest pain
attributable to PAD, (4) walking limitation by factors other
than claudication (eg, dyspnoea, angina, arthritic pain), (5)
history of intermittent claudication <6 months, and (6)
revascularization or other major surgery within the previous
6 months. Written, informed consent was obtained from
patients prior to their participation in this study. The study
was conducted according to the Declaration of Helsinki
and registered in “ClinicalTrials.gov” under reference
#NCT01484509.
All participants visited the testing facility on two occa-
sions. On visit 1, the participants ﬁrst underwent func-
tional evaluation using three “subjective” self-report
tools (self-reported maximum walking distance [SR-
MWD]; Walking Impairment Questionnaire [WIQ]; Esti-
mation of Ambulatory Capacity by History-Questionnaire
[EACH-Q]),4,13-15 followed by two “objective”evaluations (Gardner-Skinner incremental treadmill
walking test; 6-minute walking test). Questionnaire scores
were not calculated before the “objective” laboratory eval-
uations to reduce the risk of observational bias. Between
visits 1 and 2, the participants were asked to undertake
a minimum of 60 minutes of GPS-recorded unsupervised
outdoor walking in a ﬂat public park. This was aimed at
attaining an objective measure of MWD in conditions
that closely reﬂect usual community-based outdoor
walking.10 The GPS data and the data collected on visit
1 were used to assess the construct validity of the SR-
MWD, WIQ, and EACH-Q. On visit 2, which was within
7 to 10 days of visit 1, the participants repeated the subjec-
tive tests outlined above. The data collected on visit 2
were compared with those from visit 1. This was not
done to assess the test-retest reproducibility of the three
self-report tools but to assess if the resubmission of self-
report tools and prior completion of objective walking tests
changes patients’ ability to self-report.
Self-reported estimations of walking limitation
SR-MWD. The SR-MWD is the easiest way of
assessing walking limitation and was obtained using the
following written question, “What is the maximum
distance (in meters) you can walk at your usual pace on
a ﬂat surface before leg pain forces you to stop?” It allowed
a nonguided open answer and apparently remains the most
largely used approach in the routine clinical setting.
Questionnaires assessing walking limitation. The
WIQ, which was proposed over a decade ago to stan-
dardize the estimation of walking limitation by patient
interview,13 is widely used. It involves 14 items with ﬁve
possible answers for each item. The 14 items are divided
into three subscales: a distance subscale (seven items),
a speed subscale (four items), and a stair-climbing subscale
(three items). We recently proposed a new questionnaire,
the EACH-Q, for “Estimating Ambulatory Capacity by
History” in patients with claudication.14 The idea was to
try to simplify the assessment and reduce the number of
errors during self-completion.3,14 The EACH-Q estimates
the maximum duration that can be achieved (eight possible
answers ranging from “impossible” to “3 hours or more”)
at four different speeds (from “slow walking” to “running”).
Initial ﬁndings suggest that the EACH-Q has comparable
validity to the WIQ, while being easier to complete.14 The
EACH-Q was initially developed in French and had never
been tested in an English native population.
Completion, correction, and scoring of question-
naires. On arrival at the laboratory, patients were asked to
complete the SR-MWD question, the WIQ, and the
EACH-Q without help and with no time limitation. All the
questionnaires were then checked for errors by a researcher
(G.T.) as previously reported.14 Missing, duplicate (ie, two
or more answers for the same item for the EACH-Q and
WIQ), and paradoxical (ie, higher duration reported for
a higher displacement speed in the EACH-Q, or lower
difﬁculty for a higher distance in the WIQ) answers within
JOURNAL OF VASCULAR SURGERY
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Further details about the design of the EACH-Q and the
methods of error correction are reported elsewhere.14 Each
questionnaire was calculated using previously reported
valid methods.3,14,16
Fully completed WIQs were scored as previously
described.13 In brief, each level of difﬁculty was scored
from 0 (“unable to do the task”) to 4 (“no difﬁculty”).
For each item, a coefﬁcient was attributed. Each item value
was the product of the number of points by the item coef-
ﬁcient. The subscale score for distance, speed, and stair
climbing was the sum of these products divided by the
maximum possible score (14,080 for distance, 46 for
speed, and 288 for stairs). Each subscale score is expressed
as a percentage and the overall WIQ score is the mean of
the three subscale scores.
For the EACH-Q, each displacement speed was attrib-
uted a coefﬁcient: 1 for “slow walk,” 2 for “normal walk,”
4 for “fast walk,” and 7.286 for “run.” Each duration was
attributed a value consistent with its position among the
possible responses (eg, 0 for “impossible,” 1 for “30
seconds,” and 7 for “3 hours or more”). Following comple-
tion, a number of points is calculated for each displacement
speed by multiplying the corresponding coefﬁcient by the
value attributed to the duration response. The total
EACH-Q score is the sum of the calculated number of
points for all displacement speeds rounded to the nearest
whole number. It is expressed as a percentage, since by
construction, the maximum EACH-Q score is 100.
Examples for scoring of the WIQ and EACH-Q are
provided in Figs 1 and 2, respectively.
Objective measurements of MWD
Gardner-Skinner incremental treadmill walking
test. Each participant performed the Gardner-Skinner
incremental treadmill walking test, as previously de-
scribed.17 In brief, participants walked at 3.2 km/h with
a 2% increase in gradient every 2 minutes, starting from 0%.
Treadmill test duration was maximized to 20 minutes.
Participants were instructed to walk until leg pain forced
them to stop, at which point treadmill MWD was recorded.
Heart rate was recorded continuously by electrocardiogram
(Cardioperfect; Welch Allyn, Skaneateles Falls, NY).
Six-minute walk test. At least 20 minutes after the
treadmill test, participants completed a 6-minute walk
test in which they were instructed to walk as far as possible
within 6 minutes.18,19 This test is closer to community
walking conditions than treadmill testing20; however,
patients are still required to walk at a forced pace. A straight
20-m course was used, and the distance completed after 6
minutes was recorded as the “6-min-MWD.” Heart rate
was continuously monitored using heart rate telemetry
(Polar, Kempele, Finland).
GPS recording. A low-cost, commercially available
GPS data logger (DG100; GlobalSat, Taiwan) was used to
record an unsupervised walk in a designated public park
that was ﬂat and free of motorized vehicle trafﬁc and
buildings.11 This method has been described in detailpreviously.10 The participants were given clear verbal and
written instructions about how to use the GPS device and
how to perform the walking sessions. An investigator
emphasized that the aim of this session was to reproduce
their daily walk. Patients were instructed as follows: (1) to
wait for 10 minutes on arrival at the designated public park
to allow for initialization of the system; (2) to then walk at
their usual walking speed for 60 minutes, including rest
periods because of leg pain; (3) to stop at maximum
claudication pain rather than voluntarily slowing down to
avoid pain when walking discomfort starts to develop; and
(4) to wait for 2 minutes at the end of the session before
switching off the GPS device. No recommendation was
provided about the duration of rest stops. On return of the
GPS device to the investigator, the raw speed data every 2
seconds was downloaded from the GPS receiver and
analyzed using a spreadsheet system (Microsoft Excel
2000; Microsoft Corp, Redmond, Wash) as described
previously.10 Distance was retrieved from the integration of
measured speed. Since variability in distances completed
between stops is found in a 1-hour stroll with the GPS
technique,21 the longest distance observed between two
stops on the recording was used as the “GPS-MWD.”10
Sample size calculation and statistical analyses
The sample size calculation was based on the number
of patients required to ﬁnd a signiﬁcant correlation
between self-reported capacity and GPS-MWD. Assuming
a coefﬁcient of correlation (r) of at least r ¼ .484,13 and
using a two-tailed a ¼ .05 and power of 80%, the estimated
sample size was 31 (www.quantitativeskills.com). Partici-
pants were recruited until 31 complete sets of data had
been collected.
We assessed how easy the self-report tools were to
complete by calculating the proportion of tools with at
least one error and the proportion of total items with errors
(total items being the product of number of participants
and number of items in the self-report tool). Errors
included missing, duplicate, or paradoxical responses.
Normality of distribution was tested using the Shapiro-
Wilk test. Data are presented as mean 6 standard deviation
for normally distributed variables and median (25th-75th
percentiles) for non-normally distributed variables. The
correlations between subjective and objective test scores
were quantiﬁed using Pearson’s correlation coefﬁcient (r).
McNemar tests for proportions and paired t-tests for
continuous variables were used to compare the results
observed between the two sets of self-reports. Statistical
analyses were performed using Predictive Analytics Soft-
Ware Statistics v18.0 (SPSS: An IBM Company, Ports-
mouth, Hampshire, UK), and statistical signiﬁcance was
accepted at P # .05.
RESULTS
Population description. Thirty-seven patients were
recruited. Of these, six were excluded on the basis of with-
drawal after visit 1 (n ¼ 4) or incomplete data because of
noninterpretable GPS signal (n ¼ 2; prolonged satellite
WALKING IMPAIRMENT QUESTIONNAIRE (WIQ) 
Walking distance: Report the degree of physical difficulty that best describes how hard it 
was for you to walk on level ground without stopping to rest for each of the following 
distances during the last week: 
DEGREE OF DIFFICULTY DISTANCE
None Slight Some Much Unable
1. Walking indoors such as around your home? 
2. Walking 50 feet? 
3. Walking 150 feet (1/2 block)? 
4. Walking 300 feet (1 block)? 
5. Walking 600 feet (2 blocks)? 
6. Walking 900 feet (3 blocks)? 
7. Walking 1500 feet (5 blocks)? 
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
Walking speed: Report the degree of difficulty that best describes how hard it was for you to 
walk one city block on level ground at each of these speeds without stopping to rest during 
the last week: 
DEGREE OF DIFFICULTY SPEED
None Slight Some Much Unable
1. Walking one block slowly? 
2. Walking one block at an average speed? 
3. Walking one block quickly? 
4. Walking or jogging one block?
4
4
4
4
3
3
3
3
2
2
2
2
1
1
1
1
0
0
0
0
Stair climbing: For each of these questions, report the degree of physical difficulty that best 
describes how hard it was for you to climb stairs without stopping to rest during the past 
week:  
DEGREE OF DIFFICULTY STAIRS
None Slight Some Much Unable
1. Climbing one flight of stairs? 
2. Climbing two flights of stairs? 
3. Climbing three flights of stairs?
4
4
4
3
3
3
2
2
2
1
1
1
0
0
0
Fig 1. Exampleof a completedWalking ImpairmentQuestionnaire (WIQ) form.Amissing answerhas occurredon item5
of the distance subscale and has been corrected in red after self-completion. In this case, the scoring of the questionnaire
resulted in a score of 28.3%. This average score is themean of the subscale scores being for theWIQ-distance,WIQ speed,
andWIQ stairs, respectively: 24.4¼ [(4 $ 20)þ (4 $ 50)þ (3 $ 150)þ (2 $ 300)þ (2 $ 600)þ (1 $ 900)þ (0 $ 1500)]/
14.080; 31.5¼ [(3 $ 1.5)þ (2 $ 2)þ (3 $ 150)þ (2 $ 3)þ (0 $ 5)]/0.46; 29.2¼ [(3 $ 12)þ (2 $ 24)þ (0 $ 36)]/2.88.
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Table I. Demographic and descriptive variables
Whole cohort (n ¼ 37) Complete data sets (n ¼ 31)
Characteristics
Age, years 65 6 11 66 6 11
Male sex 30 (81%) 26 (84%)
Body mass, kg 78.9 6 15.8 78.0 6 15.6
Stature, cm 169 6 7 169 6 8
Body mass index, kg$m2 27.5 6 4.6 27.2 6 4.3
Ankle-brachial index 0.59 6 0.15 0.59 6 0.16
Systolic blood pressure, mm Hg 154 6 19 155 6 19
Diastolic blood pressure, mm Hg 75 6 8 75 6 9
Comorbidities
History of cardiac disease 9 (24%) 8 (26%)
History of hypertension 34 (92%) 29 (94%)
Diabetes 9 (24%) 6 (19%)
Current smoker 14 (38%) 8 (26%)
Medication
Beta-blocker 8 (22%) 6 (19%)
Other antihypertensive agent 24 (65%) 19 (61%)
Statins or other lipid-lowering agent 34 (92%) 28 (90%)
Antiplatelet or anticoagulant agent 34 (92%) 29 (94%)
Other noncardiovascular drug(s) 22 (60%) 18 (58%)
Data are mean 6 standard deviation or frequencies (%).
Fig 2. Example of a completed Estimation of Ambulatory Capacity by History-Questionnaire (EACH-Q) form. In this
case, the scoring of the questionnaire resulted in a score of 18%: (1 $ 4) þ (2 $ 3) þ (4 $ 2) þ (7.286 $ 0).
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31 patients analyzed are presented in Table I.
Self-report results. The number and proportion of
total items with errors as well as the number and propor-
tion of self-report tools with at least one error are shown
in Table II. The WIQ had the highest number of errors.
This number decreased during the second set but remained
higher than with the other tools. Table II also shows the
mean 6 standard deviation responses for each self-report
tool. Results were unchanged between sets 1 and 2,
although there was a trend for an increase in the WIQ
score.
Objective test results. The MWD values observed
were 471 m (249-741) on treadmill, 289 6 78 m on 6-
minute walking test, and 911 6 711 m on GPS, with
values ranging from 79 to 1071 m, 208 to 505 m, and 210
to 3106 m, respectively.Validity of self-reports. Table III shows the correla-
tions between the self-report and objective tests. The
correlations of self-reports to community-based outdoor
walking (ie, GPS) were consistently higher than those for
the laboratory tests (ie, treadmill and 6-minute walk tests).
This is illustrated in Fig 3. Furthermore, in most cases, the
coefﬁcients of correlation for the second set of self-reports
were higher than those for the ﬁrst set, suggesting
a learning effect had occurred, resulting in improved
accuracy of self-reporting (Table III).
DISCUSSION
The primary novel ﬁnding was that the correlations of
self-report tools with GPS-MWD were higher than with
treadmill-MWD or 6-minute-MWD.
Standard treadmill testing has been used for years with
a wide variety of protocols and is expected to provide reliable
Table III. Correlations between self-reports and objective tests of walking capacity
Correlation R SEE T P
Set 1 SR-MWD to: Treadmill-MWD .310 311 1.76 .090
6-minute-MWD .446 72 2.68 .012
GPS-MWD .579 589 3.96 .001
WIQ to: Treadmill-MWD .584 266 3.87 .001
6-minute-MWD .535 68 3.41 .002
GPS-MWD .595 581 3.98 <.001
EACH-Q to: Treadmill-MWD .378 303 2.20 .036
6-minute-MWD .515 69 3.24 .003
GPS-MWD .582 587 3.86 .001
Set 2 SR-MWD to: Treadmill-MWD .447 293 2.69 .012
6-minute-MWD .538 68 3.44 .002
GPS-MWD .808 425 7.39 <.001
WIQ to: Treadmill-MWD .420 297 2.50 .019
6-minute-MWD .414 73 2.45 .021
GPS-MWD .598 579 4.02 <.001
EACH-Q to: Treadmill-MWD .473 288 2.89 .007
6-minute-MWD .613 64 4.18 <.001
GPS-MWD .694 520 5.19 <.001
EACH-Q , Estimated Ambulatory Capacity by History-Questionnaire; GPS, global positioning system;MWD,maximum walking distance; SEE, standard error
to estimate; SR-MWD, self-reported maximum walking distance; WIQ , Walking Impairment Questionnaire.
Table II. Errors and results observed during the ﬁrst (set 1) and second (set 2) completion of self-reports
Set 1 Set 2 P
Number of errors as a proportion of total items, n (%)
SR-MWD, (1 item ∙ 31 subjects ¼ 31 items) 7 (23) 4 (13) .318
WIQ, (4 items ∙ 31 subjects ¼ 434 items) 57 (13) 22 (5) .001
EACH-Q, (14 items ∙ 31 subjects ¼ 124 items) 5 (4) 9 (7) .271
Questionnaires with at least one error, n (%)
SR-MWD 7 (23) 4 (13) .371
WIQ 18 (58) 13 (42) .132
EACH-Q 2 (7) 4 (13) .624
Self-report results
SR-MWD 200 [95-500] 250 [100-550] .154
WIQ 38 6 16 43 6 18 .051
EACH-Q 30 6 14 32 6 14 .242
EACH-Q , Estimated Ambulatory Capacity by History-Questionnaire; SR-MWD, self-reported maximum walking distance; WIQ , Walking Impairment
Questionnaire.
Fig 3. Coefﬁcients of correlation between self-reports (set 2) and
objective measures of maximal walking distance. EACH-Q, Esti-
mated Ambulatory Capacity by History-Questionnaire; GPS,
global positioning system; SR-MWD, self-reported maximum
walking distance; WIQ, Walking Impairment Questionnaire.
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not accessible. Furthermore, walking on a treadmill with
a slope does not necessarily reproduce usual walking condi-
tions. The 6-minute walking test can be performed indoors
and outdoors,22 and it correlates better with physical activity
during daily life than treadmill measures do.20
The GPS technique has recently been proposed to
attain information on walking impairment outside of the
laboratory.10,21 Although its applicability as a routine tool
remains unknown, it can provide useful information on
how patients walk in near-usual walking conditions.21
How self-reports of walking impairment correlate to
GPS-measured MWD had, to the best of our knowledge,
never been reported. The fact that questionnaires correlate
better with GPS than with other tests conﬁrm the validity
of the WIQ and EACH-Q as measures of community-
based outdoor MWD.
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different self-report tools were to complete. We observed
that patients experienced more problems completing
the one-item SR-MWD questionnaire than they did
completing the four-item EACH-Q. The high number of
missing answers with the SR-MWD question probably
relies on the difﬁculty in estimating distance in extraperso-
nal spaces23 and even familiar sites.24 The EACH-Q was
developed on the idea that time-based options are easier to
understand than distance questions. It had the lowest
proportion of errors of the three self-report tools and per-
formed much better than the WIQ in this respect, as previ-
ously found.14,16 An error in one or more item/s does not
necessarily mean that the questionnaire cannot be scored,
but previous data suggest that correction of questionnaires
improves their correlation with objective tests.16
The third point of interest relates to whether or not
patients can improve their ability to self-report. First, we
observed a reduction in errors on the second submission
of the WIQ. The correction of errors after self-
completion of the ﬁrst set might have helped patients to
better complete the WIQ at second submission. The
proportions of errors for other self-report tools did not
change, likely as a result of few errors on ﬁrst submission.
Second, we observed that the coefﬁcients of correlation
for the second set of self-reports were mostly higher than
those for the ﬁrst set. Our assumption is that, due to phys-
ical inactivity, most patients struggle to rate the difﬁculty of
walks that they do not routinely perform, and that they ﬁnd
it easier to self-report after they have faced some of these
tasks at least once.
Correlations to objective tests improved, as expected,
for both the SR-MWD and the EACH-Q, but not for
the WIQ. Importantly, the mean scores for each of the
self-report tools did not change markedly from set 1 to set
2 (Table III). The improved correlations for the SR-MWD
and EACH-Q are most likely due to the GPS session
increasing patients’ awareness of their walking limitation,
but a role for the other objective tests cannot be excluded.
However, with theEACH-Q, prior completion of a commu-
nity GPS walk would probably only improve the results for
the second item dealing with the usual speed, for which
maximum participation in the total score is 14%. The
absence of improvement of correlations with the WIQ
might be due to the way the questions are formulated.
Speciﬁcally, estimating the degree of difﬁculty to perform
the proposed tasks might be a challenging concept for
many patients.
The fact that our ﬁndings represent a single-institution
experience with a small number of patients is a limitation of
this study. Indeed, the sample size is too small for us to assess
if the coefﬁcients of correlation are statistically different from
one another. We also faced a relatively high number of drop-
outs and incomplete GPS data. The latter point was due to
poor signal quality in a region of the park that had relatively
compact trees, which underlies the difﬁculty in implement-
ing GPS experiments in nonoptimal environmental condi-
tions. Nevertheless, the ﬁnal population studied seemscomparable with previous reports on patients with intermit-
tent claudication. Another point is that, although the corre-
lations of self-reports with objective measurements were
mostly improved, it is impossible to state whether or not
this was the effect of self-report resubmission, objective
testing between the two self-reports, or both.
Our ﬁndings have important clinical implications.
Repeating self-reports after a series of objective assessments
is generally what occurs when one aims at determining the
impact of a speciﬁc intervention (eg, rehabilitation and
revascularization). Here, the clinician should be aware
that changes observed with the SR-MWD or EACH-Q
score might partly rely on the improved ability to self-
report walking limitation. Is it a good or a bad thing that
objective tests inﬂuence self-reports? It could be suggested
that a better questionnaire is the one that suffers the least
changes after the series of objective tests. On the contrary,
we think that the absence of improvement of the WIQ
correlation to objective tests illustrates its complexity, as
does its high rate number of errors, even at second comple-
tion. In practice, it could be suggested that if one aims at
using questionnaires before and after any kind of medical
or surgical intervention, an initial community-based
outdoor walk could be systematically proposed to the
patients to improve the quality of their ﬁrst estimation.
In conclusion, the fact that all self-report tools corre-
lated better with GPS results than with laboratory
data suggests that they measure what they aim to—
community-based outdoor MWD. This might explain
the previous mediocre correlations observed for self-
report tools when they were validated against laboratory
tests. The validity of self-reported walking limitation via
an open-ended single question is probably not as bad as
previously claimed,25 although some patients struggle to
provide a response. The practice of objective tests might
help patients to have a better subjective estimation of their
walking limitation. In practice, the WIQ is probably too
complex for routine clinical use. The EACH-Q represents
an alternative standardized tool but could still be improved
and needs further validation.AUTHOR CONTRIBUTIONS
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